Since NLRP3 inflammasome is crucial for the pathogenesis of NAFLD and the initiation of liver inflammatory responses, suppressing its endogenous activation may have a favorable effect in improving NAFLD. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.